Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Coplan

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Clinical Pharmacology and Therapeutics|December 24, 2010
Application of the BRAT framework to case studies: observations and insightsB S Levitan, E B Andrews, A Gilsenan, et al.
Pain Medicine (Malden, Mass.)|July 5, 2016
ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health OutcomesM Soledad Cepeda, Paul M Coplan, Nathan W Kopper, et al.
AIDS Research and Human Retroviruses|July 29, 2003
Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitorsPaul M Coplan, Alexander Nikas, Anthony Japour, et al.
The New England Journal of Medicine|February 15, 2001
Hepatitis B vaccination and the risk of multiple sclerosisA Ascherio, S M Zhang, M A Hernán, et al.
The Journal of Pain|November 7, 2012
Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatmentStephen F Butler, Theresa A Cassidy, Howard Chilcoat, et al.
Journal of Medical Internet Research|May 8, 2014
Monitoring of internet forums to evaluate reactions to the introduction of reformulated OxyContin to deter abuseEmily C McNaughton, Paul M Coplan, Ryan A Black, et al.
Pharmacoepidemiology and Drug Safety|May 17, 2019
Development of an algorithm to identify inpatient opioid-related overdoses and oversedation using electronic dataCarla A Green, Brian Hazlehurst, John Brandes, et al.
AIDS (London, England)|August 16, 2001
Indinavir did not increase the short-term risk of adverse cardiovascular events relative to nucleoside reverse transcriptase inhibitor therapy in four phase III clinical trialsP M Coplan, A A Nikas, R Y Leavitt, et al.
Postgraduate Medicine|November 14, 2019
Postmarketing studies program to assess the risks and benefits of long-term use of extended-release/long-acting opioids among chronic pain patientsPaul M Coplan, M Soledad Cepeda, Kenneth R Petronis, et al.
Sexually Transmitted Diseases|March 5, 2003
Poor sensitivity of polymerase chain reaction assays of genital skin swabs and urine to detect HPV 6 and 11 DNA in menKenneth H Fife, Paul M Coplan, Kathrin U Jansen, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|December 24, 2010
Application of the BRAT framework to case studies: observations and insightsB S Levitan, E B Andrews, A Gilsenan, et al.
Pain Medicine (Malden, Mass.)|July 5, 2016
ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health OutcomesM Soledad Cepeda, Paul M Coplan, Nathan W Kopper, et al.
AIDS Research and Human Retroviruses|July 29, 2003
Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: an analysis of four different protease inhibitorsPaul M Coplan, Alexander Nikas, Anthony Japour, et al.
The New England Journal of Medicine|February 15, 2001
Hepatitis B vaccination and the risk of multiple sclerosisA Ascherio, S M Zhang, M A Hernán, et al.
The Journal of Pain|November 7, 2012
Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatmentStephen F Butler, Theresa A Cassidy, Howard Chilcoat, et al.
Journal of Medical Internet Research|May 8, 2014
Monitoring of internet forums to evaluate reactions to the introduction of reformulated OxyContin to deter abuseEmily C McNaughton, Paul M Coplan, Ryan A Black, et al.
Pharmacoepidemiology and Drug Safety|May 17, 2019
Development of an algorithm to identify inpatient opioid-related overdoses and oversedation using electronic dataCarla A Green, Brian Hazlehurst, John Brandes, et al.
AIDS (London, England)|August 16, 2001
Indinavir did not increase the short-term risk of adverse cardiovascular events relative to nucleoside reverse transcriptase inhibitor therapy in four phase III clinical trialsP M Coplan, A A Nikas, R Y Leavitt, et al.
Postgraduate Medicine|November 14, 2019
Postmarketing studies program to assess the risks and benefits of long-term use of extended-release/long-acting opioids among chronic pain patientsPaul M Coplan, M Soledad Cepeda, Kenneth R Petronis, et al.
Sexually Transmitted Diseases|March 5, 2003
Poor sensitivity of polymerase chain reaction assays of genital skin swabs and urine to detect HPV 6 and 11 DNA in menKenneth H Fife, Paul M Coplan, Kathrin U Jansen, et al.
Pageof 7